BIAL appoints Joerg Holenz as R&D General Manager
Published on: 08/11/21
BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after over 25 years leading the company’s R&D programmes.
António Portela, CEO of BIAL said: “Joerg Holenz has a proven track record of building and leading R&D organisations. We are confident he is the right person to help us scale up our R&D projects and to strengthen the company, allowing us to continue developing innovative medicines and, above all, to contribute to our mission of improving the quality of life of people around the world.”
BIAL is an innovative international pharmaceutical company committed to improving human health and quality of life for people across the globe.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
Related content
- HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs
- Beverley Carr appointed Chief Business Officer for Amphista Therapeutics
- Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor
- Dr Kevin Eggan named as Group Vice President, Head of Research and Early Development at BioMarin
- Industry veteran Dr Steen Klysner appointed as Amarna's new CEO
